Table 1 Sociodemographic data, clinical data, and convergent variables assessed from patients in the validation study

Sociodemographic data

 Age

X

Number

 Sex

X

Male/female

Clinical data

 Presence of type-1-allergies (grass pollen, rye pollen, other cereals pollen)

X

Yes/no per option

 Anamnesis: clinical manifestations (rhinitis, conjunctivitis, asthma, neurodermatitis / atopic eczema)

X

Yes/no per option

 Anamnesis: concomitant allergies (none, birch, other trees, weeds, house dust mites, animal hair, moulds, others)

X

Yes/no per option

Convergent variables

 Global judgement of patients’ well-being (during the first grass pollen season on AIT) compared to the previous pollen season (before AIT)

X

X

Much better / somewhat better / unchanged / worse

 Severity of rhinitis symptoms

X

X

None/mild/moderate/strong

 Severity of conjunctivitis symptoms

X

X

None/mild/moderate/strong

 Frequency of rhinitis symptoms

X

X

 < 4 days per week / ≥ 4 days per week

 Duration of rhinitis symptoms

X

X

 < 4 consecutive weeks /

 ≥ 4 consecutive weeks

 Effects on sleep

X

X

Normal/impaired

 Effects on activities

X

X

Normal/impaired

 Effects on performance

X

X

Normal/impaired

 Average impairment due to rhinitis symptoms

X

X

Not at all disturbing (0) to extremely disturbing (10)

(numeric verbal visual analogue scale)

 Peak impairment due to rhinitis symptoms

X

X

Not at all disturbing (0) to extremely disturbing (10)

(numeric verbal visual analogue scale)